ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0006281;DNA repair;7.0;0.6281612110245125;0.6649999707694567;8.781226392104918;180.342582143442;3.582668236575797;0.006035903926554339;0.534137185486798;[SMARCAL1, CCNH, SMC3, CHEK1, ESCO2, CDCA5, BARD1, POLA1, BRCA1, BRCA2, CHAF1B, CHAF1A, SIRT1, RAD51C, PCNA, UNG, RAD54B, RAD54L, GINS2, RPA1, GTF2H1, MLH1, RPA3, DCLRE1A, RUVBL2, RUVBL1, MEN1, MSH6, MSH2, BLM, PSMD14, HMGA1, COPS5, JMY, CDK1, EXO1, TOPBP1, RFC5, RFC3, RFC4, RFC1, RFC2, SMC1A, DTL, POLD3, POLD1, RBBP8, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, RAD50, RAD51, POLE2]
GO:0007095;mitotic G2 DNA damage checkpoint;11.0;1.0;0.9324289523296623;9.628524252492122;857.7571147403349;6.7325511899570465;0.028708358699073767;0.7767319332797141;[MSH6, BLM, DONSON, CDK1, TOPBP1]
GO:0007098;centrosome cycle;4.0;1.0;0.75;9.628524252492122;37.692070457630365;6.088194173566533;0.0012615196775557923;0.5613505331661754;[PPP1R12A, PLK1, HEPACAM2, TUBE1, BRCA1, UXT, FES, NUP62, CDK1]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[NRP1, ECM1, CD40, SERPINE1, ITGB2, BRCA1, AQP1, CDH5, C3AR1, CTSH, CYP1B1, ITGB8, CD34, GHSR, ANXA1, ANXA3, GAB1, SIRT1, F3, SFRP2, IL1B, ADAM12, AGTR1, CHI3L1, ENG, CX3CR1, C5AR1, TWIST1, PTGS2, DLL1, THBS1, CXCR2, HMOX1, PLCG1, JUP, PLK2, TNFSF12, KLF4, LRG1, TEK]
GO:0110032;positive regulation of G2/MI transition of meiotic cell cycle;9.0;1.0;0.896240625180289;9.628524252492122;414.4836470731219;8.67846133901236;0.013872394656472954;0.8400575416471059;[CDC25A]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[, LRRK2, TNF, GHR, PROK2, TNFSF11, MAP4K1, MAP2K2, SYK, DUSP6, MDFIC, IL1B, KIT, TLR4, C5AR1, FPR1, CXCR4, TGFA, NOD2, IQGAP3, THBS1, NTF3, CCL19, DRD4, MAP2K6, EGF, MAPK14, BMP2, CD40LG, CDK1, CSPG4, PKN1]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[SPI1, EHMT2, SLA2, PHB2, MYB, HOXA2, HOXA7, MEF2A, MEF2C, HOXB4, HOXB3, ATF3, GATA3, PRDM16, ELANE, FZD1, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, PAWR, PAX5, SIRT1, PAX2, AES, MMP12, BTAF1, FLNA, NR1H2, CENPF, LGR4, GMNN, TNF, DACH1, MEN1, TLE4, FOXO1, NACC2, ZNF423, WFS1, NFKB1, BCL6, CIITA, FASLG, HHEX, EMILIN1, RFC1, PEG3, XCL1, BIRC5, RBBP8, E2F1, E2F7, PRRX1, KLF4, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, DPF3, SOX7, SOX4, RUNX2, EREG, SFRP2, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H1, IFNA2, PTPRK, BRCA1, XPO1, CD36, CBFA2T3, MDFIC, IL1B, DEPDC1, ARID4A, LOXL2, CHCHD3, BASP1, CCNE1, CALCA, TGFB1, CBX4, VDR, CAV1, HMGA1, NR4A2, BMP2, NR4A3, MXD1, CREBZF, HMGB2, MYOCD, IFNG, ELF3, FBP1, PFDN5, AURKB, SNCA, MEIS2]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[PDGFRA, TPM1, MSH2, TWIST1, GATA3, EPB41L5, CCNB2, CCNB1, PLCG1, MYH10, STIL, EIF2S2, BMP2, MAFF, PTPRR, TMEM100, HHEX, TIE1]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, JUN, JAG1, JUP, NR2F2, COL1A1, HOXC10, FOS, SIRT1, MMP12, CKS2, STAT4, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, RUVBL2, ADCYAP1, BLM, FOXO1, ZNF423, NFKB1, CXCL10, CIITA, HHEX, PPP1R12A, PEG3, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, CCNH, TNFSF11, SFRP2, EGR1, EGR2, EGR3, CD28, CD40, BRCA1, BRCA2, CD3D, RGMA, IL1B, YAP1, IL17A, CD86, CD80, CCNE1, VDR, HMGA1, INHBA, IL6, BMP2, TCF4, HMGB2, ARHGEF10L, NUP62, YWHAH, MYOCD, CCNA2, PSRC1, ELF3, CREB5, TAF9, EGF, MAPK14, CD4, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, HOXA5, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB5, NUP85, PRDM16, NKX2-3, FZD1, NFE2, FZD5, FZD8, TGFB1I1, PAX5, PAX2, ENG, EPCAM, NR1H2, GTF2H1, PF4, PLXND1, TNF, CDH1, MEN1, MAP2K2, F2R, COPS5, MAFF, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, SMARCD3, CEBPE, NOD2, ABLIM3, KLF4, KLF1, KLF5, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, BEX1, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, RHOG, MDFIC, TLR4, TLR2, LILRB1, GRHL2, CAMK4, ARID4A, ARID4B, HOXA11, HOXA10, ADRB2, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, NR4A3, SLC40A1, CKAP2, DCN, DNM2, DLL1, LUM, MEIS2, MEIS1, RBMX]
GO:0034501;protein localization to kinetochore;8.0;0.8436909121759173;0.7968454560879586;9.292052015870908;35.81813124301707;7.212124270218933;0.0011988006184784857;0.7438283705770736;[MIS12, CDK1, BUB1B, AURKB]
GO:1902042;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;10.0;0.9326813400603323;0.8815816818910864;9.589303539338841;425.73912115989816;6.193554689224359;0.014249105244888325;0.731979686697602;[SERPINE1, HMGB2, TNFAIP3, FASLG, BRCA1, HMOX1, DAPK1, TNFRSF10B, SFRP2]
GO:0065003;protein-containing complex assembly;4.0;0.45485133202666184;0.4774256660133309;6.058991556010752;36.471478728154885;2.4440506132939883;0.0012206675708314864;0.3749888620238313;[, NUP107, PRKACB, CLDN3, PADI4, PDGFC, ABCA1, JUP, FN1, COL1A1, COL1A2, HLA-DRB1, ARHGAP6, CHAF1B, CHAF1A, KCND2, ARG1, F5, SLC7A7, KCNA5, CENPA, HLA-DMA, HLA-DMB, DMD, CENPE, CENPF, CENPH, CENPI, CENPK, CENPL, CENPM, GOPC, CENPN, CENPO, KCNG2, GMNN, RUVBL2, RUVBL1, OLFM4, BLM, UQCRB, LIN7A, ACAT1, CXCL12, HLA-DRA, LRRK2, ALAD, VBP1, NDUFC2, ACPP, BDP1, NDUFB7, NDUFB6, HM13, NDUFB4, NDUFB3, NDUFB2, NDUFB1, CCL5, EIF4H, NDUFA8, NDUFA7, NDUFA6, NDUFA3, NDUFA2, IL2RB, CD247, EIF3D, CCNH, TCL1A, SNRPD2, SNRPD1, TNFSF11, FBXO5, SNRPD3, MIF, KCTD12, TGFA, PTK2, CD40, CTSZ, CD3G, CD3E, CD3D, CCT3, CCT2, FCER1G, YAP1, MIS12, CCT8, GCH1, RPA1, RPA3, NDUFAB1, NDUFB10, NDUFB11, CCNB1, H1FX, ECT2, CAV2, UBE2C, CAV1, HMGA1, NASP, TCF4, HMGB2, TNFAIP3, LAMC1, NUP62, NDUFS8, NDUFS7, NDUFS6, NDUFS4, NDUFS3, NUP54, FBP1, TAF9, SAMHD1, RRM1, EGF, TTC19, TEK, CDA, BIN2, NUP205, ACMSD, HMOX1, NCKAP1L, EHD3, SERPINA1, TK1, BRD2, GSN, GTF2H1, TNF, CLU, DACH1, MEN1, TLE4, SNRPG, SNRPE, SNRPF, NACC2, LSM3, HOPX, CDK1, EMILIN1, ADSL, VWF, TRAF1, PTBP2, MCM2, NLGN1, NLRC4, NOD2, PLN, WASF3, MARCKS, RAD51, P2RX1, IMPDH2, PPP2R1A, MCCC2, COX7A2L, TLN1, MGST1, CD79B, CD79A, VASP, AHCTF1, RAD51C, UQCR10, CTNNA1, NDUFA11, KNTC1, CHRNB4, ADRB2, NLRP3, MYH11, TGFB1, EIF2S1, AXIN2, DNM2, TGFBR3, COLEC12, HIST1H2BK, HSPD1, REPS2, RBMX]
GO:0014075;response to amine;5.0;0.7980440201809971;0.6892630219514189;9.223059144383958;29.79647000066773;6.139487467954083;9.972610358403309E-4;0.6042146864874571;[ARG1, CAD, NME1, NR4A2, CDK1, DRD4]
GO:0030261;chromosome condensation;7.0;0.8259837884571596;0.7639112594857803;9.223059144383958;23.949217433387346;6.343086423195323;8.01558754599117E-4;0.6753050999230941;[TOP2A, CDCA5, NCAPG2, SMC4, SMC2, CDK1, ACIN1, NCAPD2, NCAPD3]
GO:0008631;intrinsic apoptotic signaling pathway in response to oxidative stress;7.0;0.8653626801206646;0.7836007053175329;9.523163736834295;52.930841574252625;6.943860283624253;0.001771547632825523;0.7060287030842711;[PRKCD, MELK, CYP1B1]
GO:0008630;intrinsic apoptotic signaling pathway in response to DNA damage;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;84.23129647150353;5.54296712308321;0.002819145689655962;0.6343869617060081;[CDKN1A, BCL2A1, BRCA1, BRCA2, TNF, PYCARD, E2F1, HMOX1, SFN, MLH1, TNFRSF1B, SIRT1, MSH6, MSH2, EPHA2]
GO:0000226;microtubule cytoskeleton organization;5.0;0.579397892394798;0.5799399580583193;7.662411396119289;30.307791186580253;3.8212362582156385;0.0010143744957736317;0.4856592118117268;[UXT, CDC20, STMN1, FBXO5, MAP1B, LLGL2, FIGNL1, PLK2, PLK1, PTK2, KIF11, NUF2, TUBG1, KIF2C, CENPA, FLNA, RANBP2, RANBP1, TUBE1, CENPE, SPC25, GAS2L3, MAP7D1, MAP7D2, CCNB1, STIL, NDC80, KIF18A, FES, CDK1, NAV1, PSRC1, BIRC5, AURKB, WEE1, PRC1, RAN]
GO:0006975;DNA damage induced protein phosphorylation;8.0;1.0;0.875;9.628524252492122;212.05375489921127;7.697632086000634;0.007097248340487313;0.7686572628545723;[CHEK1, MAP2K6]
GO:0000077;DNA damage checkpoint;8.0;0.811012628672052;0.780506314336026;9.456673995565463;85.75736069739153;5.486614186532078;0.002870221685927797;0.655585704652903;[BLM, CHEK1, E2F1, TOPBP1, DONSON, MAPK14, MSH6, MSH2, CDK1]
GO:0001556;oocyte maturation;4.0;1.0;0.75;9.628524252492122;79.08984218955116;6.8867018697843045;0.0026470658418474595;0.6021862538851576;[CCNB1, FBXO5, BRCA2, EREG]
GO:0072332;intrinsic apoptotic signaling pathway by p53 class mediator;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;80.0523555558605;5.734022359845919;0.002679280298012042;0.64415753539903;[CDKN1A, BRCA2, PYCARD, PERP, TP53BP2, E2F1, E2F2, SIRT1, MSH2, JMY]
GO:0031100;animal organ regeneration;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;28.087648497102798;5.420364800990877;9.400683179555208E-4;0.5271977079954144;[CDKN1A, PCNA, C5AR1, ATIC, HMOX1, TGFB1, ANXA3, CAD, SULF2, TGFBR3, NFKBIA, CCNA2, CXCL12, NR4A3, CDK1, LCP1, EZH2]
GO:0070317;negative regulation of G0 to G1 transition;7.0;1.0;0.8509193652572005;9.628524252492122;83.03241800612349;6.139487467954083;0.002779020306340262;0.6648930398837374;[EHMT2, BRCA1, UXT, CHEK1, RBBP8, E2F1, RRM2, RAD51, TFDP1, EZH2]
GO:0048096;chromatin-mediated maintenance of transcription;11.0;1.0;0.9324289523296623;9.628524252492122;1311.6223032101445;7.57984905034425;0.043898818105007634;0.8200627852632958;[CHEK1, PADI2]
GO:0033129;positive regulation of histone phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;1473.5624568792941;7.697632086000634;0.04931880931163779;0.8088982747154926;[CCNB1, IL1B, FMR1]
GO:0071407;cellular response to organic cyclic compound;5.0;0.5310727365277519;0.5557773801247963;7.0299582842316;63.0333181336412;3.907776714546695;0.0021096684316296343;0.4900848947730398;[IL1RN, AQP9, AQP1, LGALS1, AKT1, CYP1B1, MEF2C, KCNQ1, CFTR, ABCB4, ABCA1, EGR1, JUP, COL1A1, ID1, NOX4, EZH2, GABRB1, BRCA1, ANXA1, ARG1, IL1B, PTAFR, PTGS2, GNAI1, CTNNA1, P2RY13, TNC, TNF, SLC8A1, CDH1, RUVBL2, IGFBP5, ADCYAP1, BLM, FOXO1, CCNB1, OSBPL7, TGFB1, CAV1, INHBA, NFKB1, NFKBIA, BMP2, KIF18A, NR4A3, ALPL, SLC26A3, LRRK2, PDE4B, DNM2, CCNA2, COLEC12, NOD2, P2RY6, CCL5, CCL2, SNCA, KLF4, RAD51, KLF5]
GO:0015677;copper ion import;9.0;0.8933024483968273;0.8428918493787028;9.427853557029971;21.372061049954535;7.697632086000634;7.153036497357847E-4;0.7898978880348613;[STEAP3, STEAP4, ATP7B]
GO:0055072;iron ion homeostasis;9.0;0.811012628672052;0.801746939516315;9.292052015870908;38.23288616879122;5.395046993006588;0.0012796202927058053;0.6721435792979885;[STEAP3, STEAP4, TFRC, SLC40A1, HEPH, SLC11A1, LTF, ABCG2, ABCB6, HMOX1, CYBRD1, TF, LCN2, SFXN3, RHAG]
GO:0043009;chordate embryonic development;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;22.496195207419138;4.623782033182691;7.529274083310655E-4;0.5595807407949613;[PDGFRA, TPM1, MSH2, TWIST1, GATA3, EPB41L5, CCNB2, CCNB1, PLCG1, MYH10, STIL, EIF2S2, BMP2, MAFF, PTPRR, BRCA1, TMEM100, HHEX, TIE1]
GO:0090399;replicative senescence;4.0;1.0;0.75;9.628524252492122;26.138269705024182;7.212124270218933;8.748243641116619E-4;0.6188283705770736;[CDKN1A, MME, CHEK1, SERPINE1]
GO:0007077;mitotic nuclear envelope disassembly;6.0;1.0;0.8231203125901445;9.628524252492122;74.08347249058063;7.292166977892469;0.002479507153463127;0.6960420709600095;[CCNB2, CCNB1, PLK1, CDK1, VRK1]
GO:0006260;DNA replication;7.0;0.7307253602413294;0.7162820453778652;9.271849308553389;254.20053156235352;4.77312732173501;0.008507863025766288;0.5950173184638491;[CHEK1, SLBP, BLM, BARD1, CDC6, POLA1, POLA2, NASP, CDK1, MCM7, BRCA1, CHAF1B, CHAF1A, EXO1, RFC5, RFC3, RFC4, RFC1, RFC2, RMI1, DBF4, MCM3, MCM4, MCM6, DTL, MCM2, POLD1, RBBP8, RRM1, RRM2, RPA1, DONSON, RAD50, POLE2, RPA3, DNAJA3, SSBP1]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MEF2C, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, PDGFA, IQGAP3, PDGFD, PDGFC, HMOX1, NCKAP1L, PLCG1, ELANE, LYN, JUN, FN1, CDC6, CDKN1A, HOXC10, TIMP1, HLA-DPA1, HAVCR2, ANXA1, ARG1, FCRL3, SIRT1, F3, PAX2, MMP12, HBEGF, PTAFR, KCNA5, PTGS2, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, LRG1, HLA-DPB1, CHRM1, TNC, TNF, CTGF, FGF5, PYCARD, CDH3, IGFBP5, F2R, MSH6, ADCYAP1, CD274, CSF1R, BLM, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, BCL6, CDK1, HPSE, ITGB3, FASLG, CYR61, TNFSF13B, LBH, ITGA4, XCL1, BIRC5, CX3CR1, SMARCD3, LRP2, NOD2, CCL5, E2F1, CTHRC1, PRRX1, KLF5, PRC1, DNAJA3, PTPN6, AQP1, CDC20, TCL1A, EDNRB, SKP2, TNS3, ICOSLG, SOX4, FLT3LG, MIF, RUNX2, EREG, BTC, SFRP2, TGFA, TWIST1, CD1D, PKHD1, EGR1, EGR3, TNFSF12, TNFSF13, LIF, PTK2, BST1, ID1, CD28, CD24, CD320, NRP1, NRP2, ECM1, CD40, CTSZ, PRL, CD3E, ESM1, RAC2, CTSH, CCR2, SYK, RHOG, PDCD1LG2, AVPR1A, NME1, HCK, CEACAM6, IL1B, KIT, YAP1, GNAI2, PAK1, CXCR2, LILRB2, KITLG, CD40LG, CD86, CD80, SIRPG, MPL, IL6R, PDGFRB, GHSR, PDGFRA, CCNE2, CCNE1, PRTN3, CARD11, C5AR1, LTBP3, DPP4, CCNB2, CCNB1, TGFB2, TGFB1, VCAM1, CAV2, NR4A1, IL6, BMP2, LIN28A, NR4A3, HMGB2, TNFAIP3, LAMC2, LAMC1, CXCL5, MYOCD, MMP2, GLP2R, MMP9, TGFBR3, CCNA2, ZAP70, IFNG, NDUFS4, LTA, LTF, DLL1, THBS1, S1PR3, EGF, LAMB1, MAPK14, MEIS2, TSHR, CD4, CD6, TEK]
GO:1902975;mitotic DNA replication initiation;10.0;1.0;0.9152410118609203;9.628524252492122;177.94490236465032;9.083926447120524;0.005955655742129888;0.8797934328124444;[POLA1, GINS2]
GO:0045787;positive regulation of cell cycle;5.0;0.5265193887476639;0.5535007062347522;7.230628979693751;42.184038669436575;3.8238302933926853;0.0014118618110960173;0.4857918708913159;[, CCNH, PHB2, CHEK1, AKT1, SOX4, TAS2R13, FLT3LG, MIF, EREG, BTC, CDCA5, TGFA, RACGAP1, SFN, PLK2, CDC6, CD28, CDKN1A, BRCA1, BRCA2, ANXA1, CIT, RAD51C, IL1B, CKS2, PCNA, CXCR5, KCNA5, RANBP2, RANBP1, SVIL, FAP, MAD2L1, CCNT2, CTGF, PDGFRB, CDC25A, CCNE2, CCNE1, CCNB2, CCNB1, ECT2, TGFB2, TGFB1, UBE2C, NDC80, NR4A3, CNOT3, CDK1, NUP62, CCNA2, PSRC1, TFDP1, DTL, SMARCD3, AURKB, E2F1, E2F7, SH2B1, EGF, MEIS2]
GO:1905448;positive regulation of mitochondrial ATP synthesis coupled electron transport;12.0;0.9326813400603323;0.9144609826203107;9.600353375525426;1375.5648477489242;8.390779266560578;0.04603891752616661;0.8772251544931927;[CCNB1, CDK1]
GO:0006303;double-strand break repair via nonhomologous end joining;9.0;0.8933024483968273;0.8428918493787028;9.548481544818586;368.8093148901945;5.8067817141283475;0.012343715862540626;0.693199712083778;[DCLRE1A, BLM, PSMD14, BRCA1, BARD1, MLH1, POLA1, RAD50]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, HOXA5, MEF2A, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, GATA3, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, HOXC10, PAX5, FOS, SIRT1, PAX2, MMP12, ENG, EPCAM, STAT4, NR1H2, ATAD2, GTF2H1, PSMC6, PSMC2, PF4, CCNT2, PLXND1, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, NFKB1, CXCL10, COPS5, MAFF, CIITA, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPE, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, PRRX1, KLF4, KLF1, KLF5, POU2AF1, CCNH, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, SFRP2, BEX1, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, CD28, TOP2A, CD40, PRL, BRCA1, CD3D, RGMA, IL1B, TLR4, TLR2, YAP1, LILRB1, GRHL2, IL17A, ARID4A, ARID4B, HOXA10, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYOCD, CKAP2, DCN, ELF3, TAF9, DLL1, LUM, MAPK14, MEIS2, MEIS1, RBMX]
GO:0006301;postreplication repair;8.0;0.8259837884571596;0.7879918942285797;9.500690880982237;183.0506323445446;5.8067817141283475;0.006126539929698291;0.6719590869034888;[PCNA, BRCA1, POLD3, POLD1, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, MSH2, POLE2, RPA3, DTL]
GO:0048538;thymus development;5.0;1.0;0.7902410118609202;9.628524252492122;35.890675140737365;6.039404009397101;0.0012012285974499148;0.5990964137624962;[SLC46A2, GATA3, CCNB2, HOXA3, BCL11B]
GO:0071398;cellular response to fatty acid;6.0;0.7369933605727446;0.6916169928765168;9.004369943419128;203.00017448222317;5.8067817141283475;0.006794233151624104;0.6200793994936333;[PID1, PTGER2, PTAFR, TNC, P2RY6, CCNB1, E2F1, AKT1, FFAR2, PTGDR, DGAT2, NME1, IL1B]
GO:0048146;positive regulation of fibroblast proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.74573076450893;5.825829909099042;0.0021335122412550348;0.6210535250702663;[CDKN1A, PDGFA, AQP1, CCNB1, PDGFD, MYB, PDGFC, E2F1, PDGFRB, PDGFRA, JUN, TGFB1, FN1, CDC6, MIF, EREG, BTC, CCNA2, NDUFS4]
GO:2000775;histone H3-S10 phosphorylation involved in chromosome condensation;12.0;1.0;0.9481203125901445;9.628524252492122;711.4828594708514;9.777073627680469;0.023812691013487215;0.9481203125901445;[CCNB1]
GO:0071158;positive regulation of cell cycle arrest;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;83.12201169572153;5.395046993006588;0.002782018926502022;0.6268223193749;[CDKN1A, BRCA1, SOX4, TFDP1, PCNA, CCNB1, E2F1, SFN, E2F7, TGFB1, PLK2, FAP, CNOT3, CDK1]
GO:0030521;androgen receptor signaling pathway;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;54.01143535742291;5.948432231191374;0.0018077141342769656;0.6792031009335148;[TGFB1I1, BRCA1, CCNE1, RAN]
GO:0019985;translesion synthesis;9.0;0.8933024483968273;0.8428918493787028;9.572954401337311;760.2225735865501;6.063501560976162;0.025443965382044766;0.706328376990269;[PCNA, POLD3, POLD1, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, POLE2, RPA3, DTL]
GO:2000378;negative regulation of reactive oxygen species metabolic process;6.0;0.7763722522362496;0.7113064387082693;9.253830803050711;113.12708673636307;5.905872616772578;0.003786261785297929;0.6251469128630576;[HP, BRCA1, SLC30A10, CD34, CAV1, PAX2]
GO:0014038;regulation of Schwann cell differentiation;9.0;0.8933024483968273;0.8428918493787028;9.485423408851448;65.83981520803086;8.67846133901236;0.0022035993630260702;0.8400575416471059;[CDK1]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[CDC20, RUVBL1, SKP2, CDC25A, CFTR, PSMD14, ADRB2, GATA3, NLRP3, BARD1, NFKBIA, COPS5, CDK1, TNFAIP3, BRCA1, PSMA5, CCNA2, PSMA6, PSMA3, PSMA4, PSMA2, FAM105A, USP9Y, PSMC6, PSMC2, EIF3F]
GO:0045717;negative regulation of fatty acid biosynthetic process;8.0;0.8436909121759173;0.7968454560879586;9.480104247373848;670.1384648150137;7.138016298065211;0.022428931331895798;0.7400384854347593;[CEACAM1, BRCA1, SIRT1]
GO:0006270;DNA replication initiation;7.0;0.7980440201809971;0.7499413753476991;9.405380701177911;149.0421272461911;6.343086423195323;0.0049883058697239;0.6753050999230941;[GINS2, MCM7, CDC6, POLA1, POLA2, CCNE2, CCNE1, MCM3, MCM4, MCM6, TOPBP1, MCM2]
GO:0045839;negative regulation of mitotic nuclear division;8.0;0.6997970393407541;0.724898519670377;9.076455670192082;276.53900459362586;6.166155715036245;0.009255511614802463;0.6903374900225189;[PLK1, BUB1B, CENPF, CHEK1, AURKAIP1, BUB1, MAD2L1]
GO:0000729;DNA double-strand break processing;7.0;0.811012628672052;0.7564256795932265;9.35659053700848;149.0421272461911;6.599019797332524;0.0049883058697239;0.6883935445785896;[BARD1, BLM, RAD50, EXO1, RBBP8, BRCA1]
GO:0000727;double-strand break repair via break-induced replication;10.0;1.0;0.9152410118609203;9.628524252492122;521.7226431472901;8.16763571524637;0.01746158734624478;0.8329342821725234;[GINS2]
GO:0007088;regulation of mitotic nuclear division;7.0;0.5860072649471136;0.6439229977307573;8.169909229792605;54.97351338155213;4.573066940603674;0.0018399140199305624;0.5847862212690335;[BUB1B, SMC3, PHB2, CHEK1, KNTC1, FBXO5, PDGFRB, EREG, BTC, CCNE2, CCNE1, AURKAIP1, CDCA5, TGFA, PKMYT1, CCNB2, CCNB1, TGFB1, CAV2, UBE2C, PLK1, CDC6, NDC80, STAG2, CD28, KIF11, NUP62, DUSP1, SMC1A, CCNA2, IL1B, BUB1, SH2B1, RANBP2, RANBP1, EGF, CENPE, CENPF, MAD2L1]
GO:0006271;DNA strand elongation involved in DNA replication;8.0;0.7763722522362496;0.7631861261181248;9.417215158824915;149.73527442675106;7.069023426578259;0.005011504882065279;0.7365101867784198;[POLA1, GINS2, RFC3, PCNA, RFC4]
GO:0090166;Golgi disassembly;5.0;1.0;0.7902410118609202;9.628524252492122;58.9131161342151;7.9853141584524145;0.001971768978649902;0.6986103492792611;[CDK1, VRK1]
GO:0000209;protein polyubiquitination;10.0;0.7671156992804218;0.7987988615011312;9.223059144383958;155.4032479663248;4.243684138952949;0.005201206855589802;0.6322632160784685;[SKP2, FBXW2, BARD1, HACE1, UBE2C, MARCH1, TNFAIP3, BRCA1, RNF144B, DTL, RNF24]
GO:0009263;deoxyribonucleotide biosynthetic process;9.0;0.6913464685778243;0.7419138594692012;9.253830803050711;956.1008338098185;6.943860283624253;0.03199983447272836;0.7513499630073597;[DTYMK, RRM1, RRM2]
GO:0000724;double-strand break repair via homologous recombination;9.0;0.8653626801206646;0.8289219652406215;9.515195567185119;520.6240308586224;5.299736813202263;0.01742481778162994;0.6672694122704188;[BLM, PSMD14, BRCA1, BRCA2, RAD54B, RBBP8, RAD54L, GINS2, RPA1, RAD50, RAD51, RAD51C, RPA3]
GO:0000723;telomere maintenance;7.0;0.7307253602413294;0.7162820453778652;9.292052015870908;183.01793442924338;5.266214121163619;0.006125445559899373;0.6202338003175094;[DCLRE1A, BRCA2, RFC5, RFC3, RFC4, RFC1, RFC2, RAD51C, CCNE2, CCNE1, BLM, PCNA, PRIM1, POLD3, POLD1, RPA1, POLA1, POLA2, RAD50, RAD51, RPA3]
GO:0009306;protein secretion;8.0;0.5696777571895439;0.659838878594772;7.923776160253697;130.2874189859313;4.786641040901733;0.004360602662394617;0.6197890454332871;[, IL1RN, STEAP3, TNFSF13B, CCR7, ITGB6, CD36, WLS, ANXA1, ADCYAP1, CHI3L1, LCP2, TLR6, TLR4, CARD11, TLR2, SUCNR1, NLRC4, GATA3, NOD2, NLRP3, S100A12, CCL19, LYN, ABCA1, LILRB1, CD40LG, FKBP1B]
GO:0007129;synapsis;6.0;1.0;0.8231203125901445;9.628524252492122;47.18392532465019;6.686031174322154;0.0015792035178401665;0.665044257777226;[CCNE2, CCNE1, MLH1]
GO:1903827;regulation of cellular protein localization;5.0;0.4816167172285496;0.5310493704751951;6.85593553025234;25.722958397114;3.605373030269554;8.609242683918189E-4;0.47461995629589737;[, PID1, AKT1, PRKCD, IFI27, EPHA3, EPHA2, CDCA5, TP53BP2, SFN, BARD1, JUP, FZD5, PLK1, LIF, CCT6A, PKIG, CDKN1A, XPO1, RAC2, CD36, CCT3, CCT2, FCER1G, RHOG, SIRT1, MDFIC, IL1B, RHOU, PTGS2, GNAI1, PAK1, CCT8, CCT7, CCT5, CCT4, GSN, SORBS1, NUCB1, GOPC, CHRM1, TNF, CDH1, AP2M1, CCNE2, CCNE1, ECT2, TGFB1, NDC80, CDK1, ITGAM, LRRK2, ITGB2, TREM2, NUP62, YWHAH, TFDP1, IFNG, NUP54, LCP1, LRP1, ABLIM3, E2F1, FYN, CSK, EGF, MAPK14, CD247]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[CD40, AQP1, CHEK1, AKT1, IL1B, TLR8, TLR7, TLR5, TLR4, ENG, PTGS2, TGFB1, TNFSF14, TNFRSF10B, NFKB1, COL1A1, LTBR, MYD88]
GO:0001933;negative regulation of protein phosphorylation;9.0;0.6056485694559711;0.6990649099082746;8.75603614327636;664.693789818838;3.7392027077583316;0.02224670295966317;0.5874636255457587;[PID1, PPP2R1A, AKT1, PAQR3, PRKCD, SFRP2, PRKAR1B, ATF3, TWIST1, FLRT2, PRKAR2B, SFN, LYN, JUN, PLK1, LIF, NR2F2, PKIG, CDKN1A, PTPRR, LRRC4, TIMP3, DUSP2, DUSP1, GP1BA, SIRT1, DUSP6, CEACAM1, IL1B, TLR4, ENG, LRRC19, NTF3, DMD, CDKN2C, PODN, NLRP12, PKN1, PYCARD, MEN1, TSC2, FBLN1, FOXO1, CCNB1, TGFB1, CAV1, PTPRC, LRRK2, TNFAIP3, PTPN22, HHEX, DUSP10, LRRTM4, NUP62, EMILIN1, MYOCD, IRAK3, DCN, CSK, SNCA, KLF4, PTPN6]
GO:0031442;positive regulation of mRNA 3'-end processing;10.0;0.9326813400603323;0.8815816818910864;9.590783924509275;630.6357977915417;7.57984905034425;0.021106812616712402;0.8028748447945538;[CCNB1]
GO:0010767;regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage;12.0;0.9326813400603323;0.9144609826203107;9.60185600540996;631.9844254116175;8.67846133901236;0.02115194996947028;0.8919372290569614;[CHEK1]
GO:0035407;histone H3-T11 phosphorylation;11.0;1.0;0.9324289523296623;9.628524252492122;710.1813063381824;9.083926447120524;0.02376912920145855;0.8969813732811862;[CHEK1, PKN1]
GO:0085020;protein K6-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;7.697632086000634;0.00527474598481953;0.8260862151842345;[BARD1, BRCA1]
GO:0007080;mitotic metaphase plate congression;7.0;1.0;0.8509193652572005;9.628524252492122;61.63195576956532;6.193554689224359;0.002062766094448262;0.6676580400938822;[SEH1L, CDCA5, CDCA8, CCNB1, NUP62, CENPE, KIF18A, PSRC1, KIF2C]
GO:0060045;positive regulation of cardiac muscle cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;720.414482973016;6.641579411751319;0.024111624414165377;0.7548916918429109;[TGFBR3, MEF2C, CCNB1, CDK1, MAPK14]
GO:0018108;peptidyl-tyrosine phosphorylation;9.0;0.811012628672052;0.801746939516315;9.414950152194063;338.33129968976414;4.530049555519983;0.011323644122215096;0.627907570118429;[IL5RA, SLA2, FGF5, EFEMP1, GRAP2, EPHB1, PDGFRB, PDGFRA, MAP2K2, PRKCD, EREG, BTC, MELK, BTK, EPHA3, EPHA2, BLK, CSF1R, CSF2RB, MAP2K6, LYN, LIF, BMX, CLK4, PTK2, CLK1, FES, ITK, GHR, SYK, FGR, ZAP70, HCK, LCK, KIT, IL3RA, HBEGF, FYN, CSK, IL12RB2, EGF, TIE1, WEE1, PTPN6, TEK]
GO:0007052;mitotic spindle organization;7.0;0.8259837884571596;0.7639112594857803;9.280217558223907;96.21539173928952;5.486614186532078;0.0032202425732832385;0.6315050699101035;[KIF11, AURKB, CDC20, CCNB1, STMN1, NUF2, FLNA, STIL, PLK2, TUBG1, NDC80, CENPE, BIRC5, RAN, SPC25]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[EHF, SPI1, CCNH, SPIB, MYB, HOXA7, HOXA5, SOX4, MEF2A, MEF2C, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, GATA3, NHLH2, EGR1, EGR2, JUN, BCL11B, TGFB1I1, BRCA1, HOXC10, PAX5, FOS, SIRT1, PAX2, FLNA, GTF2H1, GRHL2, CCNT2, ARID4A, HOXA10, C5AR1, HMGA1, NFKB1, COPS5, MAFF, MYOCD, TFDP1, ELF3, CREB5, CEBPE, TAF9, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, PRRX1, KLF4, MEIS2, MEIS1, KLF5, POU2AF1, TAF5, RBMX]
GO:0046777;protein autophosphorylation;8.0;0.7763722522362496;0.7631861261181248;9.31486669363708;180.75330000196035;4.488806596985934;0.006049650283656873;0.604557778120715;[SLA2, GRAP2, AKT1, EPHB1, PDGFRB, PDGFRA, MAP2K2, DAPK1, VRK1, MELK, BTK, SIK1, BLK, CSF1R, LYN, BMX, EIF2S1, CLK4, PTK2, CLK1, FES, ITK, LRRK2, MAP4K1, SYK, CAD, IRAK3, FGR, ZAP70, HCK, LCK, KIT, AURKB, PAK1, FYN, CSK, CAMK4, TEK]
GO:0043029;T cell homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;22.00128503895464;6.444869117505266;7.363632103827933E-4;0.6805102716434839;[TGFB1, SLC46A2, TNFSF14, CACNA1F, CORO1A, CCNB2, SIT1, NCKAP1L]
GO:0051445;regulation of meiotic cell cycle;5.0;0.5498737448241444;0.5651778842729924;7.5284634236095505;25.888472835594534;5.8650506222523235;8.664638876944386E-4;0.5901799734356507;[BRCA2, CDC20, PPP2R1A, FBXO5, PRKACB, DUSP1, LIF, CDC25A, MSH2, CDK1]
GO:0097202;activation of cysteine-type endopeptidase activity;12.0;1.0;0.9481203125901445;9.628524252492122;669.1123145181327;7.212124270218933;0.0223945870049345;0.8169486831672182;[PERP]
GO:0031398;positive regulation of protein ubiquitination;10.0;0.7508913569872202;0.7906866903545304;9.372590878354922;528.4459358446122;5.113634533568402;0.01768660990225356;0.6767525197159333;[LRRK2, PTPN22, BRCA1, CDC20, SKP2, ADRB2, NOD2, NDFIP2, WFS1, UBE2C, CAV1, PLK1]
GO:0072425;signal transduction involved in G2 DNA damage checkpoint;9.0;0.9326813400603323;0.8625812952104552;9.590783924509275;196.6208089386036;7.292166977892469;0.006580721527935406;0.769162383550154;[CHEK1, PLK1, BRCA1, DTL]
GO:0016055;Wnt signaling pathway;7.0;0.5916390046238794;0.6467388675691402;7.647522783625538;28.581916314885376;4.0633408221711;9.566110170045473E-4;0.558718803867703;[CELSR1, CDH3, AP2M1, SOX4, WLS, TLE4, SFRP4, HOXB9, SFRP2, CCNE1, DAAM2, PFN1, GATA3, APCDD1, FZD1, FZD5, FZD8, NR4A2, VANGL1, SDC1, SNAI2, CD24, CDK14, LRRK2, TGFB1I1, HHEX, AXIN2, AES, FRZB, CTHRC1, EGF, TMEM64, KLF4, LGR4]
GO:0016572;histone phosphorylation;8.0;0.7090535922965819;0.729526796148291;9.195660170195843;367.80445225036385;6.444869117505266;0.012310084014303157;0.7045909063862833;[PRKCD, VRK1, AURKB, CCNA2, CCNB1, CHEK1, CDK1, PKN1]
GO:0071456;cellular response to hypoxia;6.0;1.0;0.8231203125901445;9.628524252492122;103.24589989147204;5.104244793218563;0.0034555473540902374;0.5841516286869992;[SUV39H1, MPL, PHB2, SLC8A1, AQP1, AKT1, KCND2, SIRT1, CCNA2, TWIST1, PTGS2, CCNB1, E2F1, HMOX1]
GO:0010575;positive regulation of vascular endothelial growth factor production;6.0;1.0;0.8231203125901445;9.628524252492122;64.54350789155374;6.481236761676141;0.002160213123744424;0.6545710619905948;[TGFB1, C5AR1, BRCA1, PTGS2, SULF2, IL1B, C3AR1, CYP1B1, HPSE]
GO:0010971;positive regulation of G2/M transition of mitotic cell cycle;9.0;0.8933024483968273;0.8428918493787028;9.52844079393514;355.9636244052406;6.481236761676141;0.011913782162380092;0.7276913745807394;[SMARCD3, CDC25A, CCNB1, RAD51C, CDK1, DTL]
GO:0045739;positive regulation of DNA repair;8.0;0.7671156992804218;0.7585578496402109;9.360260265897443;499.6181899148078;5.8650506222523235;0.01672177118926996;0.6749389615747303;[BLM, PCNA, BRCA1, SIRT1]
GO:0045737;positive regulation of cyclin-dependent protein serine/threonine kinase activity;12.0;0.8933024483968273;0.8947715367885583;9.585964638073326;2922.0785093664276;6.193554689224359;0.09779933800857048;0.7648589874268262;[CCNT2, CCNH, CCNB1, AKT1, CDC6, PSRC1, CKS2]
GO:0033572;transferrin transport;10.0;1.0;0.9152410118609203;9.628524252492122;96.80640656383476;6.193554689224359;0.0032400233075819585;0.731979686697602;[STEAP3, TFRC, DNM2, TF]
GO:0090266;regulation of mitotic cell cycle spindle assembly checkpoint;12.0;0.8653626801206646;0.8808016526504769;9.548481544818586;280.44081179639056;7.138016298065211;0.009386101590480495;0.8131587980249038;[CCNB1, DUSP1, NDC80, MAD2L1]
GO:1901796;regulation of signal transduction by p53 class mediator;7.0;0.7192862368539868;0.710562483684194;9.117698628726131;45.070113835906206;4.948759890378168;0.001508456149618737;0.6039991761920099;[CHEK1, AKT1, MIF, SIRT1, TAF9, TWIST1, AURKB, TP53BP2, MAPK14, JMY, SNAI2, TAF5]
GO:0007344;pronuclear fusion;6.0;1.0;0.8231203125901445;9.628524252492122;29.37726267204044;9.777073627680469;9.832305438132773E-4;0.8231203125901445;[CDK1]
GO:0045732;positive regulation of protein catabolic process;7.0;0.7043150770688792;0.7030769037916401;9.033817144745429;231.0521549826792;4.39257856489138;0.0077331076938309705;0.5755560373415389;[FMR1, TNF, CLU, AKT1, ADAM9, FOXO1, BARD1, OSBPL7, PLK2, TNFSF12, CAV1, PLK1, PTK2, CCDC22, LRRK2, TNFAIP3, TNFRSF1B, CBFA2T3, RNF144B, IFNG, IL1B, DTL, LRP1, LRP2, EGF, PSMC6, PSMC2]
GO:0097186;amelogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;26.73958370240551;7.474488534686424;8.949498024565515E-4;0.7053660038532718;[SLC24A4, CSF3R, ITGB4, PERP]
GO:0030855;epithelial cell differentiation;4.0;0.5489353771682173;0.5244676885841086;6.961296045910167;21.066225782797595;4.034070439870987;7.050676185779127E-4;0.45630254989846264;[EHF, LGALS3, BASP1, AKT1, HOXA5, SOX4, MEN1, MEF2C, EREG, COL4A1, ADAM9, HOXB5, EPHA2, GATA3, PSAP, FZD1, ST14, JUN, TGFB1, JAG1, BMP2, CDK1, CD24, TGFB1I1, SLC7A11, TMEM100, HHEX, LBH, CD34, CTSB, DSP, ANXA1, PAX2, ELF3, YAP1, TAGLN, PCNA, E2F7, KLF4, USH2A, GRHL2]
GO:0071681;cellular response to indole-3-methanol;6.0;1.0;0.8231203125901445;9.628524252492122;467.4090985487011;8.16763571524637;0.01564376188754665;0.7408135829017477;[JUP, CDH1, CTNNA1, BRCA1]
GO:0010629;negative regulation of gene expression;6.0;0.471430776349301;0.558835700764795;6.738152494595957;59.04642522059629;2.349334787147576;0.001976230713800692;0.44326540286011196;[SPI1, EHMT2, SLA2, AKT1, MEF2A, MEF2C, ATF3, GATA3, IQGAP3, JUN, NR2F2, PKIG, EZH2, SIRT1, MMP12, BTAF1, FLNA, CENPF, LGR4, GMNN, CTGF, FOXO1, ZNF423, NFKB1, CIITA, LRRK2, FASLG, HHEX, ITGB8, PEG3, BIRC5, E2F1, FYN, E2F7, PRRX1, EIF3E, UXT, MIF, EREG, SFRP2, IFI27, KCNQ1, NAIP, PCBP3, CCR1, EGR1, MSR1, ID1, CD28, SUV39H1, CTSZ, PTPRK, BRCA1, CD3E, CD36, CD34, BANK1, IL1B, DEPDC1, LOXL2, CCNE1, CALCA, CCNB1, VDR, CAV1, HMGA1, BMP2, MXD1, HMGB2, MYOCD, ELF3, FBP1, AURKB, SERPINE1, PHB2, MYB, HOXA2, HOXA7, DAPK1, HOXB4, HOXB3, PRDM16, ELANE, BARD1, FZD1, NDFIP2, PLK1, FZD8, SNAI2, CDKN1A, HAVCR2, PAWR, PAX5, PAX2, AES, GAS1, ENG, NR1H2, FMR1, TNF, DACH1, MEN1, TLE4, MAP2K2, IGFBP5, NACC2, WFS1, LSM5, LSM3, BCL6, CNOT3, PTPN22, EMILIN1, CR1, RFC1, PTBP2, XCL1, NLRC4, RBBP8, ZNF503, KLF4, KLF8, KLF5, DNAJA3, ZNF608, EDNRB, PPP2R1A, MAGOH, DPF3, SOX7, SOX4, IL1R2, RUNX2, TWIST1, BCL11A, IFNA2, XPO1, CBFA2T3, NME1, MDFIC, MLH1, ARID4A, CHCHD3, BASP1, TGFB2, TGFB1, CBX4, EIF2S1, NR4A2, LIN28A, NR4A3, CREBZF, IFNG, PFDN5, THBS1, SNCA, MEIS2, RBMX]
GO:0051574;positive regulation of histone H3-K9 methylation;11.0;0.8933024483968273;0.8790801765280758;9.571365838652174;804.3299673530898;7.474488534686424;0.02692020015733362;0.8146746435927894;[MYB, BRCA1, SIRT1]
GO:0071283;cellular response to iron(III) ion;7.0;1.0;0.8509193652572005;9.628524252492122;96.28817659807011;9.083926447120524;0.003222678617004505;0.8154717862087246;[CCNB1]
GO:0007219;Notch signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;4.99795013456894;8.87013979980389E-4;0.5787157149004503;[TMEM100, HHEX, FCER2, PSEN2, KCNA5, DLL1, PLN, PERP, S1PR3, ZNF423, TGFB1, JAG1, KRT19, BMP2, SNAI2]
GO:0051572;negative regulation of histone H3-K4 methylation;11.0;0.9326813400603323;0.8987696223598284;9.59953671561887;804.8473500351352;8.390779266560578;0.026937516490087493;0.8615337942327104;[BRCA1]
GO:0051573;negative regulation of histone H3-K9 methylation;11.0;0.8933024483968273;0.8790801765280758;9.571365838652174;805.1350321075869;7.57984905034425;0.026947144950155395;0.8200627852632958;[PAX5, BRCA1, SIRT1]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, IQGAP3, JUN, JAG1, JUP, FN1, AZU1, NR2F2, COL1A1, LRRC32, HOXC10, FOS, SIRT1, MMP12, CKS2, PTAFR, STAT4, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, CTGF, RUVBL2, ADCYAP1, PKP3, BLM, FOXO1, ZNF423, NFKB1, CXCL10, MYD88, CIITA, HHEX, ITGB8, PPP1R12A, PEG3, PPP1R15A, CCL5, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, EIF3E, EIF3D, CCNH, TNFSF11, SFRP4, SFRP2, EGR1, EGR2, EGR3, ID1, CD28, CD40, BRCA1, BRCA2, CD3E, CD3D, CTSH, CD36, CD34, RGMA, IL1B, KIT, YAP1, IL17A, CD86, CD80, ACTG2, CCNE1, CCNB1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, TCF4, HMGB2, ARHGEF10L, NUP62, YWHAH, MYOCD, ACTA2, CCNA2, PSRC1, ELF3, CREB5, TAF9, EGF, MAPK14, CD4, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, HOXA5, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB5, NUP85, PRDM16, NKX2-3, FZD1, NFE2, FZD5, FZD8, TGFB1I1, PAWR, SERPINB9, PAX5, PAX2, ENG, EPCAM, GSN, NR1H2, GTF2H1, PLP1, PF4, PLXND1, FMR1, TNC, TNF, CLU, CDH3, CDH1, MEN1, MAP2K2, F2R, ADAM2, COPS5, MAFF, CDK1, PTPN22, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, SMARCD3, CEBPE, NOD2, ABLIM3, POLR2E, POLR2K, POLR2L, KLF4, KLF1, KLF5, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, BEX1, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, RHOG, MDFIC, TLR6, TLR4, TLR2, LILRB1, GRHL2, CAMK4, ARID4A, ARID4B, HOXA11, HOXA10, HGS, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, SLC40A1, CKAP2, AXIN2, DCN, DNM2, IFNG, DLL1, THBS1, LUM, MEIS2, MEIS1, RBMX]
GO:0051571;positive regulation of histone H3-K4 methylation;11.0;0.9326813400603323;0.8987696223598284;9.59953671561887;804.0422852806381;7.004484905440688;0.026910571697265715;0.7906386361357586;[MYB, BRCA1]
GO:0031145;anaphase-promoting complex-dependent catabolic process;10.0;1.0;0.9152410118609203;9.628524252492122;350.55619955642163;6.221725566191056;0.011732800519056534;0.7334203466557586;[BUB1B, AURKB, CDC20, CCNB1, UBE2C, PLK1, CDK1, MAD2L1]
GO:0070512;positive regulation of histone H4-K20 methylation;11.0;1.0;0.9324289523296623;9.628524252492122;803.63682017253;9.777073627680469;0.02689700114499224;0.9324289523296623;[BRCA1]
GO:0055015;ventricular cardiac muscle cell development;7.0;1.0;0.8509193652572005;9.628524252492122;69.56390858866273;7.379178354882098;0.002328241417009372;0.728290889492758;[CCNB1, CDK1, MYH10]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[, AKT1, STK32B, MAP2K2, PRKCD, VRK1, PRKCQ, CCNB1, PLK2, PLK1, CLK1, CDK1, LRRK2, MAP4K1, CHUK, SYK, SGK1, AURKB, MAPK14, CAMK4, PKN1]
GO:0098706;ferric iron import across plasma membrane;11.0;1.0;0.9324289523296623;9.628524252492122;329.4898826815344;7.9853141584524145;0.011027729851708358;0.8407982897480031;[STEAP3, STEAP4]
GO:0018107;peptidyl-threonine phosphorylation;9.0;0.7671156992804218;0.7797984748205;9.305750860229072;337.99482745314367;5.395046993006588;0.011312382699260763;0.6721435792979885;[LRRK2, CHEK1, AKT1, PRKCD, CAD, VRK1, CLK1, CDK1, PKN1]
GO:0046718;viral entry into host cell;7.0;0.7671156992804218;0.7344772148974115;8.935377071932177;28.374411874040543;5.346256828837156;9.496660301113433E-4;0.6243271881103005;[SCARB2, CD86, TFRC, ITGB5, CD80, ITGB3, F11R, ANPEP, CLEC5A, ITGB7, ITGB6, HAVCR1, CTSB, CR2, CR1, CXADR, EPHA2, GYPA, DPP4, NCAM1, GPR15, CDK1]
GO:0035067;negative regulation of histone acetylation;11.0;0.811012628672052;0.8379352666656883;9.498471124243924;1304.334881216342;6.943860283624253;0.04365491464912905;0.7875382901567328;[SPI1, TWIST1, BRCA1, SIRT1, SNCA]
GO:0033160;positive regulation of protein import into nucleus, translocation;10.0;1.0;0.9152410118609203;9.628524252492122;970.0189350156829;7.292166977892469;0.03246566079461078;0.7881627702307852;[IFNG, LRRK2, CDK1]
GO:0044818;mitotic G2/M transition checkpoint;10.0;0.8933024483968273;0.861892236059334;9.551563211355994;492.819650181817;6.343086423195323;0.016494230182695288;0.7396267465268138;[BLM, DONSON, CDC6, BRCA1, MSH6, CDK1, TOPBP1, NAE1]
GO:0045740;positive regulation of DNA replication;8.0;0.7671156992804218;0.7585578496402109;9.427853557029971;747.3070825002359;6.166155715036245;0.025011695518573164;0.6903374900225189;[JUN, PCNA, EREG, DBF4, CDK1, E2F7]
GO:0006468;protein phosphorylation;7.0;0.5708408884191841;0.6363398094667926;8.175090588534603;177.75756772840523;2.970244267288293;0.005949385820444992;0.5028177952168079;[, SLA2, MYLK, AKT1, PRKACB, MEF2A, MEF2C, DAPK1, PRKCD, PRKAR1B, PRKCQ, PDGFA, IQGAP3, LYN, PLK2, PLK1, CDK14, ITK, DUSP6, CIT, HBEGF, IL12RB2, GTF2H1, PKN1, CCNT2, IL5RA, TNF, FGF5, EFEMP1, GRAP2, STK32B, KCNH1, MEN1, KCNH2, MAP2K2, VRK1, NRBP1, MELK, BLK, CSF1R, PKMYT1, MAP2K6, BMX, NFKB1, CDK1, LAT, LRRK2, CHUK, LCK, IL3RA, BIRC5, NOD2, IL2RG, CCL8, CCL5, CCL2, FYN, CSK, TIE1, IL2RB, PTPN6, CCNH, CHEK1, RPS6KA1, TNFSF11, EPHB1, PAQR3, EREG, BTC, BTK, SIK1, ALPK2, EPHA3, EPHA2, LIF, PTK2, CTSH, CTSG, CCR5, SPTAN1, MAP4K1, SYK, HCK, IL1B, KIT, TLR7, SGK1, TLR4, TLR2, PAK1, PRKY, KITLG, CAMK4, BUB1B, PDGFRB, PDGFRA, CCNE1, CSF2RB, RASGRP4, SPTA1, CCNB1, TGFB2, TGFB1, EIF2S1, CLK4, CLK1, BMP2, FES, GHR, CAD, IRAK3, TGFBR3, FGR, CCNA2, ZAP70, SHANK3, AURKB, NCAM1, BUB1, EGF, MAPK14, WEE1, TEK]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[LGALS1, SKP2, ESCO2, SPARCL1, SDC2, FN1, TF, SERPINA1, TIMP1, F5, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, PSMC6, PSMC2, NUCB1, TNC, MEN1, IGFBP5, APLP2, FBXW2, PSMD14, CUL5, IGFBP7, NAE1, WFS1, IL6, COPS5, CCDC22, UBE2M, LAMC1, CYR61, DTL, LAMB1]
GO:0000079;regulation of cyclin-dependent protein serine/threonine kinase activity;11.0;0.7866048967936545;0.8257314007264895;9.474373572664863;340.6851601099881;5.181953777545879;0.011402425712143147;0.6974343094988531;[CDKN1A, CCNT2, CCNH, TNFAIP3, HHEX, AKT1, MEN1, MYOCD, CDC25A, CCNA2, PSRC1, CCNE2, CCNE1, CKS2, BLM, PKMYT1, CCNB2, CCNB1, SFN, CDKN2C, PLK1, GTF2H1, CDC6, NR2F2]
GO:0060623;regulation of chromosome condensation;7.0;0.8259837884571596;0.7639112594857803;9.377209824211215;21.750886949199476;8.390779266560578;7.279826116623381E-4;0.7800242071602487;[CCNB1]
GO:0006978;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;8.0;1.0;0.875;9.628524252492122;145.46952913610525;7.004484905440688;0.004868734226108882;0.7332096838060964;[CDKN1A, BRCA1, BRCA2]
GO:2000617;positive regulation of histone H3-K9 acetylation;12.0;1.0;0.9481203125901445;9.628524252492122;1488.212472397538;7.8311634786251565;0.049809132146875434;0.8486063770733797;[GATA3, BRCA1]
GO:0046680;response to DDT;5.0;1.0;0.7902410118609202;9.628524252492122;46.407574972267774;9.777073627680469;0.0015532197702158826;0.7902410118609202;[CCNB1]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[SPI1, EHMT2, SLA2, MYB, HOXA2, HOXA7, MEF2A, MEF2C, HOXB4, HOXB3, ATF3, GATA3, PRDM16, ELANE, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, PAWR, PAX5, SIRT1, AES, MMP12, NR1H2, TNF, DACH1, MEN1, TLE4, FOXO1, NACC2, WFS1, NFKB1, BCL6, CIITA, FASLG, HHEX, RFC1, PEG3, RBBP8, E2F1, E2F7, PRRX1, KLF4, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, SOX7, SOX4, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H1, XPO1, CD36, IL1B, LOXL2, CHCHD3, CCNE1, TGFB1, CBX4, VDR, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, IFNG, FBP1, AURKB, SNCA, MEIS2]
GO:0045471;response to ethanol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;69.73224034292265;5.006389003214805;0.0023338753293357085;0.5462679783062231;[SPI1, SPARC, TNC, EEF1B2, ALAD, ADCYAP1, CLDN3, IL1B, CLDN7, S100A8, PSMD14, GATA3, CCL7, CNR1, FYN, CD14, GSN, VCAM1, CDK1]
GO:0000086;G2/M transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;43.44612409677276;4.981283082083729;0.0014541026745458175;0.5449840603320351;[CDKN1A, PPP2R1A, SKP2, TUBG1, CDC25A, CIT, DNM2, CCNA2, MELK, PKMYT1, CCNB2, CCNB1, PRKAR2B, PLK1, WEE1, CDK1, CDK14]
GO:0006977;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;11.0;1.0;0.9324289523296623;9.628524252492122;888.119660647831;5.75172193694532;0.0297245657860804;0.7265722796674696;[CDKN1A, PCNA, CCNB1, E2F1, SFN, E2F7, SOX4, PLK2, TFDP1, CNOT3, CDK1]
GO:0032508;DNA duplex unwinding;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;23.726073882073138;5.734022359845919;7.940903407527885E-4;0.64415753539903;[BLM, MCM7, RAD54B, RUVBL2, RUVBL1, GINS2, ANXA1, HMGA1, RPA1, RAD50, RAD51, MCM4, MCM6, MCM2]
GO:0000083;regulation of transcription involved in G1/S transition of mitotic cell cycle;10.0;0.8933024483968273;0.861892236059334;9.541512875502493;264.067998117236;6.444869117505266;0.008838118251214853;0.7448319182472036;[PCNA, RRM2, CDC6, POLA1, TFDP1, CCNE1, E2F1, FBXO5, E2F7]
GO:2000615;regulation of histone H3-K9 acetylation;11.0;0.8933024483968273;0.8790801765280758;9.533214072687796;182.99191619144386;7.379178354882098;0.006124574752895117;0.8098004765652196;[CHEK1, GATA3, BRCA1]
GO:0000082;G1/S transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;42.752976916212816;5.142344639450834;0.0014309036622044387;0.5532207558659172;[CDKN1A, MCM7, GMNN, SKP2, CDC25A, DBF4, CCNE2, CCNE1, MCM3, MCM4, RHOU, MCM6, BCAT1, MCM2, CUL5, PRIM1, IQGAP3, RBBP8, RANBP2, RANBP1, CDKN2C, PLK2, RPA1, CDC6, INHBA, POLA1, POLA2, WEE1, NASP, POLE2, RPA3]
GO:0034644;cellular response to UV;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;66.19362175939281;5.420364800990877;0.0022154409498949313;0.628117073252615;[CDKN1A, FMR1, PTPRK, AQP1, RUVBL2, CHEK1, MME, SIRT1, CDC25A, PCNA, PTGS2, AURKB, POLD1, EIF2S1, MFAP4]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[PID1, BRCA1, PYCARD, TCL1A, AKT1, CHUK, SIRT1, CHI3L1, XCL1, CCL13, CALCA, GATA3, ADAMTS12, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, CCL23, VCAM1, CCL21, CCL20, MAPK14, NFKB1, COL1A1]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[PCNA, TNFAIP3, FOXO1, AQP1, IL18RAP, PDGFD, MYB, CYP1B1, ECT2, ANXA1, ARG1, PRKCD, KLF4, SIRT1, PAX2, IL6, CDK1, EZH2]
GO:0051987;positive regulation of attachment of spindle microtubules to kinetochore;7.0;0.8653626801206646;0.7836007053175329;9.485423408851448;141.20478198009135;8.16763571524637;0.004725996976820352;0.7686126355688037;[CCNB1]
GO:0035335;peptidyl-tyrosine dephosphorylation;8.0;0.8933024483968273;0.8216512241984136;9.52844079393514;179.24922260518233;5.181953777545879;0.005999310166768488;0.6400053571691908;[PTPRR, PTPN22, PTPRK, DUSP10, DUSP2, DUSP1, DUSP6, CDC25A, TPTE, PTPRE, PTPRC, PTPN6]
GO:0051865;protein autoubiquitination;10.0;1.0;0.9152410118609203;9.628524252492122;155.4032479663248;5.769740442447999;0.005201206855589802;0.7103058064080809;[BRCA1]
GO:0042769;DNA damage response, detection of DNA damage;5.0;0.7866048967936545;0.6835434602577475;9.143016436710422;39.83823472227698;6.139487467954083;0.0013333498640710748;0.6042146864874571;[PCNA, POLD3, POLD1, SOX4, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, RPA3, DTL]
GO:0046600;negative regulation of centriole replication;11.0;0.9326813400603323;0.8987696223598284;9.590783924509275;466.4695881312043;7.697632086000634;0.015612317319377515;0.8260862151842345;[BRCA1]
GO:0045995;regulation of embryonic development;5.0;0.5017827139744404;0.5411323688481404;6.887684228566921;27.37613670804801;4.981283082083729;9.162546586948941E-4;0.5449840603320351;[IL1RN, CELSR1, PRKACB, DUSP6, SFRP2, LAMA3, GATA3, DLL1, RACGAP1, FZD1, KLF4, CDK1]
GO:0006633;fatty acid biosynthetic process;8.0;0.6493065804076676;0.6996532902038338;8.912904216080118;359.8485513982277;5.076593261888053;0.01204380717262807;0.6346172154986847;[TECR, BRCA1, ELOVL4, ELOVL6, MIF, ELOVL7, MGST1, PTGS2, CYP3A4, PTGS1, ALOX5, PNPLA8, SCD, NDUFAB1, PLP1]
GO:0042246;tissue regeneration;4.0;0.7586651285174919;0.629332564258746;8.935377071932177;42.88961059103013;6.039404009397101;0.0014354766683382502;0.5588554019015759;[GSN, CCNB1, NINJ1]
GO:0006359;regulation of transcription by RNA polymerase III;10.0;0.8436909121759173;0.837086467948879;9.52844079393514;248.56913769389934;6.481236761676141;0.008319385340914571;0.7466917612613706;[BRCA1, BDP1]
GO:0007569;cell aging;3.0;0.7980440201809971;0.597142322680643;8.935377071932177;24.751975343904395;5.618190544320798;8.284263394289076E-4;0.485434838299289;[CDKN1A, SERPINE1, BRCA2, NUP62, CHEK1, MME, PRKCD, HMGA1, MIF, MAPK14, SIRT1, DNAJA3, CDK1, NOX4, ENG]
GO:0006513;protein monoubiquitination;10.0;0.8653626801206646;0.8479223519212526;9.574457031221845;155.4032479663248;5.649939242635378;0.005201206855589802;0.704179167478338;[DTL]
GO:0046602;regulation of mitotic centrosome separation;9.0;0.8933024483968273;0.8428918493787028;9.503361109538115;111.3333211242262;7.212124270218933;0.003726226064543951;0.7650689957573628;[RANBP2, RANBP1, CHEK1, KIF11]
GO:0006511;ubiquitin-dependent protein catabolic process;8.0;0.7369933605727446;0.7434966802863723;9.190269321560967;156.4521708431119;3.582668236575797;0.005236313360306564;0.5582178202295975;[, CDC20, SKP2, HACE1, PLK1, TGFB1I1, SIRT1, PSMA5, PSMA6, RNF144B, PSMA3, PSMA4, PSMA2, RANBP2, RANBP1, USP9Y, PSMC6, PSMC2, MAD2L1, BUB1B, PSMD14, CUL5, CCNB1, WFS1, UBE2C, CDK1, DTL, AURKB, RNF24]
GO:0006349;regulation of gene expression by genetic imprinting;7.0;0.8933024483968273;0.7975705894556142;9.577230958104572;130.9317736178294;6.8867018697843045;0.004382168632042727;0.7031056191423581;[KCNQ1, ARID4A, ARID4B, BRCA1]
GO:0044030;regulation of DNA methylation;7.0;0.7980440201809971;0.7499413753476991;9.253830803050711;73.34977914704017;6.7325511899570465;0.0024549510975359675;0.6952223462072524;[SPI1, BRCA1, GRHL2]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SERPINE1, PHB2, AKT1, PROK2, MEF2C, DAPK1, PRKCD, CLDN7, PRKCQ, GATA3, SLC30A10, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, AZU1, SNAI2, CDKN1A, CHL1, TIMP1, ANXA1, DUSP1, ANXA5, SERPINB9, SIRT1, PAX2, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, PF4, TNF, CLU, CLEC5A, F2R, ADCYAP1, MSH2, CSF1R, BLM, CORO1A, FOXO1, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, CXCL12, COPS5, BCL6, CDK1, MYD88, LRRK2, FASLG, CYR61, TNFRSF1B, ADAMTS20, BIRC5, CX3CR1, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, IL2RB, IL1RN, SLC46A2, AQP1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB1, FLT3LG, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, PTK2, VNN1, ID1, CD28, NRP1, BRCA1, CTSH, CCR7, CCR5, FCER1G, HCK, RNF144B, CEACAM6, IL1B, KIT, YAP1, IFI6, GNAI2, CXCR2, PDPN, CTNNA1, LILRB1, CD40LG, GRINA, MAD2L1, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, STIL, CBX4, CAV1, NR4A2, NFKBIA, IL6, NR4A3, HMGB2, SLC40A1, TNFAIP3, NUP62, MYOCD, MMP9, NDUFS3, LTF, BCL2A1, TAF9, DLL1, THBS1, AURKB, HSPD1, SNCA, TEK]
GO:0097711;ciliary basal body-plasma membrane docking;5.0;1.0;0.7902410118609202;9.628524252492122;21.38880323109876;5.223196736079928;7.158639954716971E-4;0.5573555358475362;[PPP2R1A, TUBG1, PRKAR2B, PLK1, CDK1]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[MYB, AKT1, CYP1B1, HOXA5, MEF2C, DAPK1, PRKCD, ATF3, HMOX1, SFN, PLCG1, BARD1, LYN, JUN, NOX4, CTLA4, TIMP3, ANXA1, DUSP1, PAWR, SIRT1, F3, DUSP6, AES, PTGS2, FGD3, FGD4, FRZB, GSN, BIK, G0S2, TNF, CTGF, PYCARD, F2R, MELK, MAL, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, PLEKHF1, FASLG, CYR61, ITGA4, TFDP1, LCK, NLRC4, CCL5, E2F1, CCL2, P2RX1, MNDA, PPP2R1A, SOX7, SOX4, TIAM2, SFRP4, SFRP2, IFI27, SIK1, INPP5D, TP53BP2, TNFSF12, ITM2C, TOP2A, CD40, CTSZ, CTSH, VAV1, IL1B, CXCR2, CTNNA1, SORT1, LILRB1, PPP1CA, NLRP12, CD40LG, FAP, DLC1, PDGFRB, NLRP3, ECT2, TGFB2, TGFB1, VDR, CAV1, INHBA, EIF2S1, IL6, BMP2, NR4A3, JMY, UBE2M, YWHAH, MMP9, DNM2, IFNG, LTA, BCL2A1, THBS1, HSPD1, CNR1, SNCA, HSPE1, LTBR]
GO:2000620;positive regulation of histone H4-K16 acetylation;13.0;1.0;0.9625549647676366;9.628524252492122;1673.9769773112196;9.083926447120524;0.056026502949136;0.9271073857191605;[BRCA1]
GO:0033147;negative regulation of intracellular estrogen receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;234.23542340630428;7.138016298065211;0.007839648823214116;0.7400384854347593;[LBH, BRCA1, PHB2]
GO:0010569;regulation of double-strand break repair via homologous recombination;9.0;0.8436909121759173;0.8180860812682478;9.523163736834295;184.48234756552796;6.221725566191056;0.00617445814968456;0.7144199599751273;[BLM, RAD51, FIGNL1, CHEK1]
